We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Zhinous Yazdi MD

Zhinous Shahidzadeh Yazdi MD

Postdoctoral Research Fellow, University of Maryland School of Medicine, Baltimore, Maryland

Dr. Zhinous Shahidzadeh Yazdi, MD, received an MD degree from Kerman University of Medical Sciences (Iran) in 2010 - after which she completed a four-year residency in Internal Medicine at Tehran University of Medical Sciences (2013-2017). From completion of medical school to her immigration to the US in January of 2020, Dr. Yazdi worked as a primary care physician and later as an internist in a variety of clinical environments from rural to urban and inpatient to outpatient settings. Of her extensive clinical experience, she values the opportunity of seeing and helping patients in underserved areas and rural Iran the most.

Dr. Yazdi, also worked as a basic science research trainee and later research assistance in a cell culture and embryology lab during her medical school and worked mostly on projects in stem cell, embryology, and infertility fields.

Dr.Yazdi joined the Endocrinology Division at University of Maryland School of Medicine as a post-doctoral fellow in the research group of Dr. Simeon Taylor (Professor of Medicine) in June 2020.

Her T32-supported research focuses on SGLT2 inhibitors with special emphasis on precision medicine and drug-associated safety issues. Her primary post-doctoral research project is to investigate the nutrient-drug interaction between vitamin D and canagliflozin. Her research demonstrated that vitamin D deficiency may increase vulnerability to adverse effects of SGLT2 inhibitors on biomarkers related to bone health and that vitamin D supplementation may be protective. Her work has been presented at three national meetings.


Dr. Yazdi has no relevant disclosures.